{"id":"https://openalex.org/W2732103305","doi":"https://doi.org/10.1200/jco.2017.35.15_suppl.e15010","title":"Clinical and genomic alterations features of patients with advanced colitis associated cancers (CAC).","display_name":"Clinical and genomic alterations features of patients with advanced colitis associated cancers (CAC).","publication_year":2017,"publication_date":"2017-05-20","ids":{"openalex":"https://openalex.org/W2732103305","doi":"https://doi.org/10.1200/jco.2017.35.15_suppl.e15010","mag":"2732103305"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2017.35.15_suppl.e15010","doi":"https://doi.org/10.1200/jco.2017.35.15_suppl.e15010","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2017.35.15_suppl.e15010","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069929201","display_name":"David Paul Kelsen","orcid":"https://orcid.org/0000-0001-6139-438X","observed_orcids":["https://orcid.org/0000-0001-6139-438X"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Paul Kelsen","raw_affiliation_strings":["Memorial Sloan-Kettering Cancer Center, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Center, New York, NY;","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111578811","display_name":"Vincent A. Miller","orcid":"https://orcid.org/0000-0003-1667-3771","observed_orcids":["https://orcid.org/0000-0003-1667-3771"]},"institutions":[{"id":"https://openalex.org/I4392738181","display_name":"Foundation Medicine (United States)","ror":"https://ror.org/02ackr434","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4392738181"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vincent A. Miller","raw_affiliation_strings":["Foundation Medicine, Inc., Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Foundation Medicine, Inc., Cambridge, MA;","institution_ids":["https://openalex.org/I4392738181"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021215219","display_name":"Laura H. Tang","orcid":"https://orcid.org/0000-0001-5735-9354","observed_orcids":["https://orcid.org/0000-0001-5735-9354"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laura H. Tang","raw_affiliation_strings":["Memorial Sloan-Kettering Cancer Center, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Center, New York, NY;","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045756365","display_name":"Marinela Capanu","orcid":"https://orcid.org/0000-0003-4953-3193","observed_orcids":["https://orcid.org/0000-0003-4953-3193"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marinela Capanu","raw_affiliation_strings":["Memorial Sloan-Kettering Cancer Center, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Center, New York, NY;","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054324336","display_name":"Sohail Balasubramanian","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4392738181","display_name":"Foundation Medicine (United States)","ror":"https://ror.org/02ackr434","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4392738181"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sohail Balasubramanian","raw_affiliation_strings":["Foundation Medicine, Inc., Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Foundation Medicine, Inc., Cambridge, MA;","institution_ids":["https://openalex.org/I4392738181"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088559019","display_name":"Jeffrey S. Ross","orcid":"https://orcid.org/0000-0001-8494-2596","observed_orcids":["https://orcid.org/0000-0001-8494-2596"]},"institutions":[{"id":"https://openalex.org/I4392738181","display_name":"Foundation Medicine (United States)","ror":"https://ror.org/02ackr434","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4392738181"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey S. Ross","raw_affiliation_strings":["Foundation Medicine, Inc., Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Foundation Medicine, Inc., Cambridge, MA;","institution_ids":["https://openalex.org/I4392738181"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113642947","display_name":"Philip J. Stephens","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4392738181","display_name":"Foundation Medicine (United States)","ror":"https://ror.org/02ackr434","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4392738181"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Philip J. Stephens","raw_affiliation_strings":["Foundation Medicine, Inc., Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Foundation Medicine, Inc., Cambridge, MA;","institution_ids":["https://openalex.org/I4392738181"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5038339239","display_name":"Rona D. Yaeger","orcid":"https://orcid.org/0000-0002-7233-5454","observed_orcids":["https://orcid.org/0000-0002-7233-5454"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rona Yaeger","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY;","institution_ids":["https://openalex.org/I1334819555"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"35","issue":"15_suppl","first_page":"e15010","last_page":"e15010"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.7314000129699707,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.7314000129699707,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11369","display_name":"Genetic factors in colorectal cancer","score":0.1662999987602234,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":0.030300000682473183,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/colitis-associated-cancer","display_name":"colitis-associated colorectal cancer","score":0.9549999833106995},{"id":"https://openalex.org/keywords/metastatic-colorectal-cancer","display_name":"metastatic colorectal cancer","score":0.9240000247955322},{"id":"https://openalex.org/keywords/inflammatory-bowel-disease","display_name":"inflammatory bowel disease","score":0.9769999980926514},{"id":"https://openalex.org/keywords/somatic-alterations","display_name":"somatic alterations","score":0.9269999861717224},{"id":"https://openalex.org/keywords/tp53-mutation","display_name":"TP53 mutation","score":0.8579999804496765},{"id":"https://openalex.org/keywords/kras-mutation","display_name":"KRAS mutation","score":0.9829999804496765},{"id":"https://openalex.org/keywords/fgfr-inhibitors","display_name":"FGFR inhibitors","score":0.7540000081062317},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.7210000157356262},{"id":"https://openalex.org/keywords/folfox","display_name":"FOLFOX","score":0.6840000152587891},{"id":"https://openalex.org/keywords/folfirinox","display_name":"FOLFIRINOX","score":0.8799999952316284},{"id":"https://openalex.org/keywords/folfiri","display_name":"FOLFIRI","score":0.8989999890327454},{"id":"https://openalex.org/keywords/survival-outcomes","display_name":"survival outcomes","score":0.515999972820282},{"id":"https://openalex.org/keywords/braf-mutation","display_name":"BRAF mutation","score":0.6169999837875366},{"id":"https://openalex.org/keywords/pik3ca","display_name":"PIK3CA","score":0.6930000185966492},{"id":"https://openalex.org/keywords/eml4-alk-fusion","display_name":"EML4-ALK fusion","score":0.7570000290870667},{"id":"https://openalex.org/keywords/idh1","display_name":"IDH1","score":0.7649999856948853}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9298257827758789},{"id":"https://openalex.org/C2778260052","wikidata":"https://www.wikidata.org/wiki/Q117636","display_name":"FOLFOX","level":5,"score":0.8045831918716431},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.7268442511558533},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7108292579650879},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.6417385935783386},{"id":"https://openalex.org/C2776705615","wikidata":"https://www.wikidata.org/wiki/Q1389369","display_name":"FOLFIRI","level":5,"score":0.6133407950401306},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.592540442943573},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.5524829030036926},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.4834064543247223},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4359123110771179},{"id":"https://openalex.org/C2777909004","wikidata":"https://www.wikidata.org/wiki/Q420207","display_name":"Capecitabine","level":4,"score":0.4356522560119629},{"id":"https://openalex.org/C2780962732","wikidata":"https://www.wikidata.org/wiki/Q422327","display_name":"Oxaliplatin","level":4,"score":0.42998677492141724},{"id":"https://openalex.org/C2780259306","wikidata":"https://www.wikidata.org/wiki/Q412197","display_name":"Irinotecan","level":4,"score":0.42548471689224243},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4146645963191986},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3904667794704437},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2017.35.15_suppl.e15010","doi":"https://doi.org/10.1200/jco.2017.35.15_suppl.e15010","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2017.35.15_suppl.e15010","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2890062901","https://openalex.org/W2612362186","https://openalex.org/W4391096122","https://openalex.org/W2321327051","https://openalex.org/W3004536638","https://openalex.org/W3004540501","https://openalex.org/W2333856427","https://openalex.org/W2811461664","https://openalex.org/W2887475063","https://openalex.org/W2605880088"],"abstract_inverted_index":{"e15010":[0],"Background:":[1],"CAC":[2,18,37,57,75,90,156,166,278,309],"are":[3,157,303],"a":[4,255,265,273],"catastrophic":[5],"complication":[6],"of":[7,13,23,45,79,112,127,144,190,194,308],"inflammatory":[8],"bowel":[9,89],"disease.":[10],"The":[11,123],"spectrum":[12],"genomic":[14],"alterations":[15,235],"(GA)":[16],"in":[17,76,141,178,227,238,300,305],"is":[19,50,268],"different":[20],"than":[21,43,207],"that":[22,44,208,289],"sporadic":[24,46,292,301],"colorectal":[25],"cancer":[26],"(CRC)":[27],"(Yaeger":[28],"et":[29],"al":[30],"PMID":[31],"27063727).":[32],"While":[33],"the":[34,77,142],"prognosis":[35],"for":[36,55,71,104,151,173,210,220,291],"patients":[38,218],"(pts)":[39],"may":[40],"be":[41],"worse":[42],"CRC":[47,302],"pts,":[48],"there":[49],"little":[51],"data":[52,135],"regarding":[53],"outcome":[54,70,139,299],"metastatic":[56,74,155,174,195],"pts":[58,72,153,161,182,211,240,253,279,310],"treated":[59],"with":[60,73,101,154,162,212,285,297],"standard":[61],"chemotherapy":[62],"regimens.":[63],"We":[64,84],"reviewed":[65,140],"demographic":[66],"features":[67,150],"and":[68,87,99,133,138,183,230],"clinical":[69,134],"context":[78,143],"somatic":[80,145],"tumor":[81,146],"GA.":[82,122,147,314],"Methods:":[83],"identified":[85,226],"small":[86],"large":[88],"cases":[91],"seen":[92],"at":[93],"Memorial":[94],"Sloan":[95],"Kettering":[96],"between":[97],"2003":[98],"2015":[100],"tissue":[102],"available":[103],"study.":[105],"Hybrid":[106],"capture":[107],"based":[108,258],"next-generation":[109],"sequencing":[110],"analysis":[111],"over":[113],"300":[114],"cancer-related":[115],"genes":[116],"was":[117,130,136,197],"used":[118],"to":[119,264],"comprehensively":[120],"characterize":[121],"electronic":[124],"medical":[125],"record":[126],"each":[128],"patient":[129,271],"reviewed.":[131],"Demographic":[132],"extracted":[137],"Results:":[148],"Clinical":[149],"17":[152],"shown":[158],"below.":[159],"All":[160],"initial":[163],"stage":[164],"III":[165],"received":[167,254],"FOLFOX":[168],"adjuvant":[169,186],"therapy.":[170,187],"First-line":[171],"treatment":[172],"disease":[175,196],"included":[176],"FOLFOX/FOLFIRINOX/FU-LV":[177],"10":[179],"previously":[180],"untreated":[181],"FOLFIRI":[184],"after":[185],"Median":[188],"duration":[189],"survival":[191,286],"from":[192],"time":[193],"14.8":[198],"months,":[199],"(95%":[200],"CI":[201],"5.7-24.3;range":[202],"2-68+":[203],"months),":[204],"substantially":[205],"less":[206],"expected":[209,290],"Stage":[213],"IV":[214],"CRC.":[215,293],"Only":[216],"4":[217],"survived":[219],">":[221],"24":[222],"months.":[223],"GA":[224],"were":[225,236],"TP53":[228],"(87%)":[229],"KRAS":[231],"(33%);":[232],"potentially":[233,312],"targetable":[234,313],"found":[237],"8":[239],"(":[241],"IDH1":[242],"(1),":[243],"EML4-ALK(1),":[244],"ERBB2":[245],"(1);":[246,250],"FGFR1/2":[247],"(3);":[248],"BRAF":[249,294],"PIK3CA(1).":[251],"2":[252],"targeted":[256],"agent":[257],"on":[259],"GA;":[260],"1":[261],"partial":[262],"response":[263],"FGFR":[266],"inhibitor":[267],"ongoing.":[269],"No":[270],"had":[272,311],"hyper-mutated":[274],"tumor.":[275],"Conclusions:":[276],"Metastatic":[277],"have":[280],"an":[281],"exceedingly":[282],"poor":[283,298],"prognosis,":[284],"well":[287],"below":[288],"mutations":[295],"associated":[296],"rare":[304],"CAC.":[306],"47%":[307],"[Table:":[315],"see":[316],"text]":[317]},"counts_by_year":[],"updated_date":"2026-10-22T18:32:59.640997","created_date":"2017-07-14T00:00:00"}